ASHG: Nabsys Links Cytogenetics and Genomics to Map Hematologic Cancers
Blood cancers carry complex genomic rearrangements that no single assay fully captures. At ASHG 2026 in Montréal, Nabsys presented early data comparing its Electronic Genome Mapping technology with established cytogenetic methods and previewed new analysis software for hematologic malignancies. The post ASHG: Nabsys Links Cytogenetics and Genomics to Map Hematologic Cancers appeared first on GEN…
We haven't written up this one. GEN Biotechnology has the full story — the link below goes straight to it.
